Nuclear factor 1 (NFI)

Nuclear factor 1 (NFI) is a family of site-specific DNA-binding transcription factors, comprising NFIA, NFIB, NFIC, and NFIX, that are essential for vertebrate development and viral DNA replication [1, 2, 5]. Originally identified as host factors required for adenovirus replication, NFI proteins are now recognized as master regulators of organogenesis, particularly in the maturation of the central nervous system, lungs, and skeleton [2, 10]. They function by binding to the palindromic consensus sequence TTGGC(N5)GCCAA as homodimers or heterodimers, where they act as transcriptional activators or repressors depending on the cellular context and target promoter [2, 5]. In humans, germline mutations in NFI genes are linked to severe neurodevelopmental disorders, such as Malan syndrome (NFIX) and various brain malformations involving the corpus callosum (NFIA, NFIB) [1, 5, 10]. Additionally, the family is frequently dysregulated in cancer, where members can exhibit either oncogenic or tumor-suppressive properties in malignancies such as small cell lung cancer, prostate cancer, and glioblastoma [8, 11]. Although currently considered difficult to target directly with small molecules, NFI activity is an emerging area of therapeutic research, particularly through indirect strategies such as the use of BET inhibitors to modulate their expression and activity in tumors [5, 9].

Other names

Nuclear factor INFI familyCTFCCAAT-binding transcription factorTGGCA-binding proteinNF-1

Modulation of gene transcription through site-specific DNA binding to consensus sequences and recruitment of co-regulators; also acts as a host-encoded protein facilitating the initiation of viral DNA replication.